{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:29:28Z","timestamp":1771014568643,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1023\/a:1008380527502","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"1293-1297","source":"Crossref","is-referenced-by-count":105,"title":["Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy"],"prefix":"10.1016","volume":"10","author":[{"given":"I.F.","family":"Khouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Korbling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Anderlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"von Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gajewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008380527502_bb0005","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma \u2013 an entity comes of age","volume":"87","author":"Weisenberger","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1200\/JCO.1993.11.4.802","article-title":"Intermediate lymphocytic lymphoma. Clinical and pathologic features of a recently characterized subtype of non-Hodgkin\u2019s lymphoma","volume":"11","author":"Shivdasani","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0015","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood.V87.10.4358.bloodjournal87104358","volume":"87","author":"Pittaluga","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0020","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","article-title":"Mantle-cell lymphoma: Correlation of clinical outcome and biologic features with three histologic variants","volume":"15","author":"Majlis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0025","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate-cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","article-title":"High-dose chemo-radiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission","volume":"16","author":"Freedman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2141.1997.272673.x","article-title":"Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease","volume":"97","author":"Khouri","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1023\/A:1008380527502_bb0040","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.1995.13.5.1096","article-title":"Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma. The case for aggressive management","volume":"13","author":"Van Besien","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0045","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","article-title":"Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Verdonck","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0050","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma","volume":"92","author":"Van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0055","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1987.5.9.1340","article-title":"Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation","volume":"5","author":"Applebaum","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0060","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1991.9.10.1848","article-title":"Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors","volume":"9","author":"Lundberg","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0070","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","article-title":"Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma: A case-controlled analysis of the European Bone Marrow Transplantation Group Registry Data","volume":"10","author":"Chopra","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0075","first-page":"591","article-title":"Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin\u2019s lymphoma","volume":"12","author":"Shepherd","year":"1993","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma","volume":"84","author":"Ratanatharathorn","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology","volume":"100","author":"Van Besien","year":"1996","journal-title":"Am J Med"},{"key":"10.1023\/A:1008380527502_bb0090","first-page":"893","article-title":"T-cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin\u2019s lymphoma. Clinical and molecular follow-up","volume":"21","author":"Juckett","year":"1998","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0095","first-page":"369","article-title":"Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma","volume":"20","author":"Dann","year":"1997","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2141.1998.00539.x","article-title":"Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"100","author":"Mandigers","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1023\/A:1008380527502_bb0105","first-page":"977","article-title":"Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect","volume":"19","author":"Van Besien","year":"1997","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0110","first-page":"669","article-title":"Graft-versus-leukemia after allogeneic bone marrow transplantation for chronic lymphocytic leukemia","volume":"18","author":"Rondon","year":"1996","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0115","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: Induction of graft-versus-malignancy using fludarabine based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0120","first-page":"455","article-title":"Allogeneic blood stem-cell transplantation in advanced hematologic cancers","volume":"19","author":"Przepiorka","year":"1997","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0125","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-hosl disease after matched unrelated donor marrow transplantation","volume":"88","author":"Przepiorka","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0130","first-page":"867","article-title":"Development of a single probe for documentation of chimerism following bone marrow transplantation","volume":"41","author":"Yam","year":"1987","journal-title":"Am J Hum Genet"},{"key":"10.1023\/A:1008380527502_bb0135","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380527502_bb0140","first-page":"825","article-title":"Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"BMT"},{"key":"10.1023\/A:1008380527502_bb0145","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leuke-mias with the t(II; 14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1023\/A:1008380527502_bb0150","first-page":"1437","article-title":"Chromosome t(ll:14)(ql3:q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-l major translocation cluster","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"key":"10.1023\/A:1008380527502_bb0155","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11:14) by polymerase chain reaction in mantle-cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0160","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1073\/pnas.86.13.5123","article-title":"Detection of minimal residual disease in hematopoietic malignancies of the B-cell lineage by using third-complementary-determining region (CDR-III)-specific probes","volume":"86","author":"Yamada","year":"1989","journal-title":"Proc Natl Acad Sei USA"},{"key":"10.1023\/A:1008380527502_bb0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0092-8674(81)90400-1","article-title":"Structure of the human immunoglobulin F locus: Characterization of embryonic and rearranged J and D genes","volume":"27","author":"Ravetech","year":"1981","journal-title":"Cell"},{"key":"10.1023\/A:1008380527502_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1008380527502_bb0175","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0180","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0185","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.174.1.27","article-title":"Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes","volume":"174","author":"Falkenburg","year":"1991","journal-title":"J Exp Med"},{"key":"10.1023\/A:1008380527502_bb0195","first-page":"1148","article-title":"Separation of graft- versus-host disease and graft-versus-leukemia against chronic myelogenous leukemia","volume":"23","author":"Champlin","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1023\/A:1008380527502_bb0200","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: Harnessing graft-versus-leukemia without myelo-ablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0205","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008380527502_bb0210","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem-cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341957418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341957418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/11\/1293\/19477139\/10-11-1293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:36:41Z","timestamp":1582223801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341957418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["S092375341957418X"],"URL":"https:\/\/doi.org\/10.1023\/a:1008380527502","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}